Telespirometry in Amyotrophic Lateral Sclerosis (ALS)

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 28, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

December 30, 2024

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DIAGNOSTIC_TEST

Spirometry

All study participants will undergo pulmonary function testing using conventional spirometry in clinic and portable spirometry in clinic and at home. In-clinic conventional laboratory spirometry is compared with portable spirometry and Slow vital capacity is obtained in upright and supine positions.

Trial Locations (2)

13210

SUNY Upstate, Syracuse

28211

Atrium Health, Charlotte

Sponsors
All Listed Sponsors
collaborator

Mitsubishi Tanabe Pharma America Inc.

INDUSTRY

lead

State University of New York - Upstate Medical University

OTHER